Winterfield Jeffrey R, Jensen James, Gilbert Therese, Marchlinski Francis, Natale Andrea, Packer Douglas, Reddy Vivek, Mahapatra Srijoy, Wilber David J
Loyola University Medical Center, Maywood, Illinois.
St. Jude Medical, St. Paul, Minnesota.
J Cardiovasc Electrophysiol. 2016 Jan;27(1):102-9. doi: 10.1111/jce.12835. Epub 2015 Nov 18.
Next-generation catheters have been developed to reduce irrigation volume and preserve power delivery. A novel design uses a flexible tip (FlexAbility™ catheter) that directs flow to the contact surface. Because of recent safety issues with new catheters, we undertook a study in a canine heart with 3 irrigated catheters to compare efficacy and safety.
Endocardial ablation was performed by 2 independent operators in 12 anesthetized canines with the FlexAbility (St. Jude Medical), ThermoCool™ (Biosense Webster), and ThermoCool™ SF (Biosense Webster) catheters. Endocardial RF lesions were delivered with each catheter in all 4 chambers of each animal for 52 ± 16 seconds. Each chamber was randomized to receive ablation from one catheter with recording of safety events. Cardiac pathology was performed with triphenyl tetrazolium chloride stain.
Average lesion dimensions were not significantly different between the 3 catheters. FlexAbility™ demonstrated a lower risk of steam pops relative to ThermoCool SF (P-value = 0.013) despite equal mean power and radiofrequency time. High-temperature generator shutdowns were observed with FlexAbility™ but not with either ThermoCool catheter. High-temperature shutdowns were associated with larger average impedance drops (28.5 ohms vs. 19 ohms) without compromising lesion size.
The FlexAbility™ tip is safe and effective with no significant difference in lesion sizes compared to both standard ThermoCool and ThermoCool SF. FlexAbility™ has a significantly lower risk of steam pops compared to ThermoCool SF in a beating heart as defined predominantly by an abrupt rise of impedance.
已开发出新一代导管以减少冲洗量并保持能量输送。一种新颖的设计采用了可将血流导向接触面的柔性尖端(FlexAbility™导管)。由于新型导管最近出现了安全问题,我们在犬类心脏中使用3种灌注导管进行了一项研究,以比较其有效性和安全性。
由2名独立操作人员对12只麻醉犬使用FlexAbility(圣犹达医疗公司)、ThermoCool™(强生公司)和ThermoCool™ SF(强生公司)导管进行心内膜消融。在每只动物的所有4个心腔中,使用每种导管进行心内膜射频消融52±16秒。每个心腔随机接受一种导管的消融,并记录安全事件。采用氯化三苯基四氮唑染色进行心脏病理学检查。
3种导管之间的平均损伤尺寸无显著差异。尽管平均功率和射频时间相同,但FlexAbility™相对于ThermoCool SF显示出较低的蒸汽泡风险(P值=0.013)。观察到FlexAbility™出现高温发生器关闭情况,而两种ThermoCool导管均未出现。高温关闭与较大的平均阻抗下降有关(28.5欧姆对19欧姆),但不影响损伤尺寸。
FlexAbility™尖端安全有效,与标准的ThermoCool和ThermoCool SF相比,损伤尺寸无显著差异。在跳动的心脏中,FlexAbility™相对于ThermoCool SF具有显著更低的蒸汽泡风险,主要表现为阻抗突然升高。